Stay updated on Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.2 replacing v3.2.0; no study details, eligibility criteria, or results are altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:21:45.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Removed the global government-funding notice about possible delays and operating status. There are no changes to the study details, eligibility criteria, or trial outcomes on the page.
    Difference
    0.4%
    Check dated 2025-11-18T06:49:34.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The two screenshots show only superficial UI changes to the study page; core study information (title, conditions, eligibility, interventions, outcomes) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:39:14.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Core content updated to reflect a new operating-status notice and a new version (v3.2.0); previous version v3.1.0 removed.
    Difference
    5%
    Check dated 2025-10-06T04:55:53.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content.
    Difference
    0.1%
    Check dated 2025-09-29T02:55:55.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, indicating a new release. The 'Back to Top' element was removed, a minor UI change.
    Difference
    0.3%
    Check dated 2025-09-14T18:55:59.000Z thumbnail image

Stay in the know with updates to Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page.